Director/Sr. Director, Market Access

Lupin PharmaceuticalsSomerset, NJ
11d$190,000 - $230,000

About The Position

Overview Lupin is comprised of a fast growing, innovative and robust team of manufacturing, Research and Development and commercial divisions. Together these entities make up the generic and branded U.S. business. Lupin has a significant generic pipeline, and a branded focus on women’s health. Our first Research and Development facility in the US is located in Coral Springs, Florida which focuses on generic and branded orally inhaled and nasal drug products. Somerset, New Jersey is home to one of Fifteen commercial manufacturing sites globally and the only commercial manufacturing facility in the United States for Lupin, as well as additional Research and Development teams. Lupin is prided on being people-focused and centered around how impactful we are with our customers. Dollars are not a measure of success but rather the people we help along the way. The Director, Market Access – Generics Business will be a key member of Lupin’s Commercial and Biosimilar team, responsible for developing and executing market access strategies for Lupin’s generic specialty portfolio including biosimilars and 505b2 products. This role will focus on assessing payer and GPO opportunities, providing strategic insights into customer decision-making, and ensuring optimal access for Lupin’s specialty products across all relevant channels. The position requires close coordination with internal departments such as Finance, Contract Analytics & Distribution, Legal, Trade and Distribution, and Commercial Operations.

Requirements

  • Bachelor’s degree required
  • Minimum of 5 years of market access experience in the generics and/or biosimilars pharmaceutical industry.
  • Proven understanding of Commercial, Medicare, Medicaid, and Federal payer segments.
  • Knowledge of pharmacy vs. medical reimbursement methodologies, pricing/reimbursement authorities’ decision-making processes, and current pricing issues relevant to 505 (b)(2) and biosimilars.
  • Self-starter with entrepreneurial drive and a track record of achieving market access goals and objectives.
  • Strategic thinker with both a long-term view of the business and a focus on driving immediate results.
  • Impeccable ethics and integrity, with strong compliance to legal and regulatory parameters.
  • Executive presence with excellent communication skills.
  • Customer-facing experience with basic marketing and strong sales skills.
  • Ability to travel at least 30%

Nice To Haves

  • Pricing & Contracting within the generics and/or biosimilars pharmaceutical industry.
  • Payer & GPO account management for generics and biosimilars.
  • New product launch and pre-commercialization experience for generics and biosimilars.
  • Established relationships with hospital and institutional GPOs, health plans, and other stakeholders relevant to generics.
  • Experience in market access for biosimilars and 505b2 products.

Responsibilities

  • Develop and implement market access objectives for generics, biosimilars, and 505b2 products by building strong customer relationships and securing favorable formulary status, medical policy, and coverage within targeted payer channels.
  • Prepare contract business cases, conduct ROI assessments and scenario planning, and ensure contract compliance and data management for all contracted accounts.
  • Create and maintain account dashboards with current account profiles, coverage policies, formulary management, customer interactions, and key marketplace intelligence.
  • Proactively share access and relevant price information with internal Lupin stakeholders.
  • Support Lupin’s mission, vision, core values, and customer service philosophy, and adhere to the Corporate Compliance Program, including all regulatory and company policy requirements.
  • Foster relationships with and influence organized customer stakeholders, including payers, health systems, and GPOs, with a focus on 505 (b)(2) and biosimilars.
  • Collaborate with cross-functional teams to support new product launches and pre-commercialization activities for 505 (b)(2) and biosimilars
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service